Main Article Content

A double-blind trial in hypertension comparing baycaron (FBA 1500), hydrochlorothiazide and placebo


Geoffery Dean
Steyn Louw
Colin Hersch
H.O. Kirsten
D.N. Brereton
L. Finnemore
J. Dewar

Abstract

A double-blind study carried out on volunteer patienls with medium to severe grade II hypertension, did not show any slatistically significant difference between treatment
with Baycaron 25 mg daily and hydrochlorothiazide 50 mg daily.


Journal Identifiers


eISSN: 2078-5135
print ISSN: 0256-9574